?25 million revolving loan facility

RNS Number : 5415O

The MedicX Fund Limited

20 September 2013

 

For immediate release

20 September 2013

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

£25 million revolving loan facility

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom, is pleased to announce that it has completed a £25 million revolving loan facility with The Royal Bank of Scotland Plc.  The facility is for a three year term at a rate based on a margin over LIBOR, set dependent on group loan to value.  At current rates the facility is expected to cost approximately 3%.  

The Fund has £279.7 million of other debt facilities with a weighted average fixed cost of 4.45% including undrawn amounts, with an average remaining term of 15.9 years. 

David Staples, Chairman of MedicX Fund, said:

"I am delighted to announce this new debt facility.  This complements MedicX Fund's existing long term debt facilities and enables us to commit to investments without putting fixed term debt in place on day one.  The facility will then be drawn to fund further commitments and repaid on any future fundraising, enabling the Fund to manage its cash more efficiently."

- End -

For further information please contact:

MedicX Group                                                                [phone]
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer

MedicX Fund Limited                                                       [phone]
David Staples, Chairman

Canaccord Genuity Limited                                              [phone]
Andrew Zychowski / Lucy Lewis  

Buchanan                                                                     [phone]
Charles Ryland / Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange in November 2006.  It has committed investment of £449.7 million and a portfolio of 122 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group.  The MedicX Group is a specialist investor, developer and manager of healthcare properties with 30 people operating across the UK. 

The company's website address is www.medicxfund.com.  Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement. 

 

END

 

 

MSCLLFLLATIIFIV